Seeger Weiss Represents Arlington County, Virginia in Insulin Pricing Lawsuit

Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other […]

November 14, 2023

Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other diabetes medications.

Over the past 20 years, the cost of insulin has risen several hundred percent, far outpacing the increase in the cost of production. This price inflation has not only placed a heavy financial burden on individuals who require insulin to manage their diabetes but also on government entities like Arlington County that bear the brunt of these inflated prices. The lawsuit seeks to recover damages for the increased costs borne by Arlington County due to the alleged pricing scheme and to prevent these companies from continuing their alleged unlawful, deceptive, and anticompetitive practices.

This case reflects Seeger Weiss’ ongoing commitment to representing clients in important public health litigation. The firm currently represents several government entities, including Albany County, New York; Lake County, Illinois; Monmouth County, New Jersey; the City of Cleveland, Ohio; and others that have filed similar lawsuits alleging that insulin manufacturers and PBMs are complicit in overcharging for these life-saving diabetes medications. Additionally, Seeger Weiss and its co-counsel successfully argued for the creation of a multidistrict litigation for these insulin pricing lawsuits in the District of New Jersey. The Judicial Panel on Multidistrict Litigation created the In re: Insulin Pricing Litigation MDL in August of this year.

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Related News

August 22, 2025
Fifteen Seeger Weiss Attorneys Selected For Inclusion in the 2026 Edition of The Best Lawyers in America

Seeger Weiss LLP is proud to announce that 15 of its attorneys have been selected for inclusion in the 2026 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and […]

Read More
August 4, 2025
Lawdragon Names Five Seeger Weiss Partners to 2025 500 Leading Global Litigators List

Lawdragon has recognized five Seeger Weiss partners—Chris Seeger, Stephen Weiss, David Buchanan, Jennifer Scullion, and Parvin Aminolroaya—in their 2025 Lawdragon 500 Leading Global Litigators list. This annual guide honors lawyers who “assiduously work to resolve disputes between nations, bring justice for human rights abuses, address financial fraud that crosses borders and unearth stashed assets.” The […]

Read More
July 31, 2025
Seeger Weiss Founding Partner Christopher Seeger Appointed Plaintiffs’ Lead Negotiation Counsel in Johnson & Johnson Talcum Powder Litigation

Seeger Weiss founding partner Christopher Seeger has been appointed Plaintiffs’ Lead Negotiation Counsel in the Johnson & Johnson Talcum Powder Litigation by the Honorable Judge Rukhsanah L. Singh of the District of New Jersey. The multidistrict litigation includes nearly 60,000 pending cases of women who developed ovarian cancer after using Johnson & Johnson’s Baby Powder, […]

Read More